NORMAN, OKLA. – The University of Oklahoma has awarded nearly $200,000 in pilot seed funding to 20 artificial intelligence projects designed to spark innovation across health care, education, research and digital infrastructure. These faculty-led initiatives span a wide range of disciplines, showcasing OU’s commitment to empowering responsible and transformative uses of AI.
“These staff and faculty-led projects will move fast and create deliverables by the end of August,” said Yessenia Torres, senior managing director for the OU Data Institute for Societal Challenges, which is administering the initiative. “The researchers who are leading the projects will host office hours and workshops to invite anyone interested in their topics to learn more. The goal is to share their models so that others can replicate them."
The funded projects are:
Learn more about AI at OU, including research, use cases, news and more.
About the University of Oklahoma
Founded in 1890, the University of Oklahoma is a public research university located in Norman, Oklahoma. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. For more information about the university, visit www.ou.edu.
University of Oklahoma College of Medicine Associate Professor Lee Jennings, M.D., chief of the Division of Geriatrics and Palliative Medicine in the Department of Internal Medicine, has been selected for the Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) program, one of the nation’s top leadership fellowships in academic health care.
The University of Oklahoma community came together once again in a powerful show of generosity during its annual Giving Day, raising over $29.6 million to support causes university-wide.
Results from a Phase 3 clinical trial offer new hope for patients with advanced pancreatic cancer, showing the experimental drug daraxonrasib significantly extended survival compared with chemotherapy alone. Researchers at the University of Oklahoma Health Stephenson Cancer Center enrolled patients in the global trial.